miR-19a promotes cell growth and tumorigenesis through targeting SOCS1 in gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 835-840

  Qin, Shuang ^a   Ai, Fang ^a   Ji, Wei Fang ^a   Rao, Wang ^a   Zhang, He Cheng ^a   Yao, Wen Jian ^a  

^a The Third Hospital of Xinxiang Medical University   (China)

Author keywords

Cell growth; Gastric cancer; miR 19a; SOCS1

Indexed keywords

MICRORNA; MIRN19 MICRORNA, HUMAN; OLIGONUCLEOTIDE; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

3' UNTRANSLATED REGION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES; STOMACH NEOPLASMS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION;

EID: 84877655064     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.835     Document Type: Article

References (26)

1. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33.
2. Clevenger CV (2004). Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol, 165, 1449-60.
3. Davey GM, Heath WR, Starr R (2006). SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens, 67, 1-9.
4. Ding L, Xu Y, Zhang W, et al(2010). MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res, 20, 784-93.
5. Du Y, Xu Y, Ding L, et al(2009). Down-regulation of miR- 141 in gastric cancer and its involvement in cell growth. J Gastroenterol, 44, 556-61.
6. Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.
7. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
8. Friedman RC, Farh KK, Burge CB, et al(2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res, 19, 92-105.
9. Gao C, Zhang Z, Liu W, et al(2010). Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer, 116, 41-9.
10. Guo X, Guo L, Ji J, et al(2010). miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun, 398, 1-6.
11. Jemal A, Bray F, Center MM, et al(2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
12. Jiang S, Zhang HW, Lu MH, et al(2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70, 3119-27.
13. Krebs DL, Hilton DJ (2001). SOCS proteins: negative regulators of cytokine signaling. Stem Cells, 19, 378-87.
14. Lai RH, Hsiao YW, Wang MJ, et al(2010). SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett, 288, 75-85.
15. Lee TL, Yeh J, Van Waes C, et al (2006). Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther, 5, 8-19.
16. Liu M, Wang Z, Yang S, et al(2011). TNF-α is a novel target of miR-19a. Int J Oncol, 38, 1013-22.
17. Oshimo Y, Kuraoka K, Nakayama H, et al(2004). Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer, 112, 1003-9.
18. Ouchida M, Kanzaki H, Ito S, et al(2012). Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach. PLoS One, 7, e44095.
19. Pichiorri F, Suh SS, Ladetto M, et al(2008). MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA, 105, 12885-90.
20. Shi Y, Zhou Y (2010). The role of surgery in the treatment of gastric cancer. J Surg Oncol, 101, 687-92.
21. Slattery ML, Lundgreen A, Kadlubar SA, et al(2013). JAK/ STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog, 52, 155-66.
22. Souma Y, Nishida T, Serada S, et al(2012). Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells. Int J Cancer, 131, 1287-96.
23. Ueda T, Volinia S, Okumura H, et al(2010). Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol, 11, 136-46.
24. Wu Q, Jin H, Yang Z, et al(2010). MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun, 392, 340-45.
25. Xu XM, Wang XB, Chen MM, et al(2012). MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett, 322, 148-58.
26. Zhang Z, Li Z, Gao C, et al(2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest, 88, 1358-66.